Long-term antibacterial activity of vancomycin from calcium phosphate cement in vivo

Manabu Mukai1, Kentaro Uchida1,2, Ken Sugo3

  • 1Department of Orthopaedic Surgery, Kitasato University School of Medicine, Minamiku, Sagamihara, Kanagawa, Japan.

Abstract

Insights

Calcium phosphate cement (CPC) loaded with vancomycin (VCM) demonstrated superior long-term antibiotic release and antibacterial activity compared to polymethylmethacrylate (PMMA) in vivo. This suggests CPC is a promising material for treating periprosthetic joint infections.

Area of Science:

  • Biomaterials Science
  • Infectious Disease Research
  • Orthopedic Surgery

Background:

  • Periprosthetic joint infection is a serious complication of total joint arthroplasty.
  • Current treatment involves two-stage exchange and systemic antibiotics, which can have limited efficacy due to poor tissue penetration.

Purpose of the Study:

  • To evaluate the in vivo release profile and antibacterial activity of vancomycin (VCM) from calcium phosphate cement (CPC/VCM).
  • To compare CPC/VCM with polymethylmethacrylate impregnated with VCM (PMMA/VCM) over a 24-week period.

Main Methods:

  • Rats were implanted with CPC/VCM and PMMA/VCM specimens.
  • Residual VCM was extracted after 24 weeks to determine release concentrations.
  • Antibacterial activity was assessed using agar diffusion assays with Staphylococcus aureus.

Main Results:

  • CPC/VCM released significantly higher concentrations of VCM for a longer duration (24 weeks) compared to PMMA/VCM.
  • Antibacterial activity showed a logarithmic correlation with VCM concentration.
  • CPC/VCM exhibited larger inhibition zones than PMMA/VCM throughout the study period.

Conclusions:

  • CPC/VCM demonstrates superior sustained release of VCM with potent antibacterial activity compared to PMMA/VCM.
  • CPC is effective in facilitating local antibiotic delivery for managing postoperative joint infections.

Related Concept Videos